NAFDAC Director-General Paid a Courtesy Visit to LUTH to Strengthen Research Collaboration

The Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Professor Mojisola Christianah Adeyeye, accompanied by her team and representatives of the Bill & Melinda Gates Foundation, paid a courtesy visit to the Lagos University Teaching Hospital (LUTH)


The delegation was warmly received by the Chief Medical Director (CMD), Professor Wasiu Lanre Adeyemo, alongside members of the hospital’s management team. In his welcome remarks, the CMD expressed pride in hosting the DG and her team and commended NAFDAC for its consistent efforts in safeguarding public health. He particularly acknowledged the agency’s proactive steps in withdrawing expired and substandard drugs from the market, noting that such actions are critical to ensuring patient safety and maintaining trust in the healthcare system.



In her address, Professor Adeyeye spoke about a proposed two-year collaborative research project between NAFDAC and LUTH. She explained that the initiative is designed to strengthen research capacity and generate findings that will have meaningful impact on healthcare delivery and society at large. She emphasized that collaboration between regulatory agencies and tertiary health institutions remains essential in addressing emerging health challenges and improving standards of care.

In response, the CMD sought clarification on what would be required from LUTH to ensure the successful execution of the project. He also asked about the processes and procedures that would guide the collaboration, as well as whether there would be feedback and dissemination of findings after the completion of the research, emphasizing the importance of feedback to ensure the project delivers tangible and impactful results.

The visit concluded on a positive note, with both institutions reaffirming their commitment to strengthening partnerships that advance research, regulatory excellence, and quality healthcare delivery.